Leng and colleagues demonstrated that MEHP treatment promoted the phosphorylation of Akt and the degradation of IκB-α, thus activating NF-κB and enhancing NF-κB nuclear translocation, which enhanced metastasis formation of ovarian cancer xenografts. The gene discussed is NFKB1; the disease is ovarian cancer.